Clinical trial · Observational
Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
Validation of Serum Pepsinogen II and Helicobacter Pylori Test in the Detection of Gastric Cancer in South Korea
NCT06301464CI-TRIAL-00083107active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study to validate the role of pepsinogens in gastric cancer screening.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Patients with gastric neoplasms
- description
- Patients with gastric neoplasms
- label
- Normal control
- description
- Normal control without gastric neoplasms
Primary outcomes (1)
- measure
- The level of serum pepsinogens
- timeFrame
- At the time of enrollment
- description
- To compare the level of serum pepsinogens between the two groups
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Who undergoes serum pepsinogens and anti-H. pylori antibody tests, and esophagogastroduodenoscopy during a health-screening examination at Seoul National University Hospital Gangnam center (SNUHGC) or Seoul National University Bundang Hospital (SNUBH) Exclusion Criteria: * Who do not receive serum pepsinogens or anti-H. pylori antibody studies * Who do not receive esophagogastroduodenoscopy within 3 months before or after the date of serum pepsinogens and anti-H. pylori antibody tests * Subjects with recent proton-pump inhibitor therapy 1 month prior to enrollment * Subjects with prior history of gastrectomy * Subjects with upper gastrointestinal neoplasms other than gastric adenoma/adenocarcinoma * Subjects who do not agree to participate in the study or withdraw his/her consent
References
Publications (0)
Data not yet available
No reference posted for this study.